Search
for
Sort by
Research 151–180 of 1000+
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review
- Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID ‐19 pandemic
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Ethnobotanical, Phytochemical, Toxicological, and Pharmacological Properties of Ziziphus lotus (L.) Lam.: A Comprehensive Review
- A selection of eleven plants used as traditional Polynesian cosmetics and their development potential as anti-aging ingredients, hair growth promoters and whitening products
- Application of Acyzol in the Context of Zinc Deficiency and Perspectives
- Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals—Insights into Microbial Dysbiosis: Final Results
- Nanofat in Plastic Reconstructive, Regenerative, and Aesthetic Surgery: A Review of Advancements in Face-Focused Applications
- A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Performance and Tolerance of a Protocol for Idiopathic Chronic Greasy Seborrhea in 18 Dogs Using a Shampoo and Mousse Containing Plant Extracts
- Wounds and the Microbiota: The Healing Interplay Between Host and Microbial Communities
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Isolation and identification of hair growth potential fraction from active plant extract of Blumea eriantha DC grown in Western Ghat of India: In silico study
- Exploration of Natural Adsorbents for Applications in Pollution-Reducing Cosmetic Formulations
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Effectiveness of an Autologous Micrografting Technology for Treating Stretch Marks
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Aesthetic Rehabilitation Medicine: Enhancing Wellbeing beyond Functional Recovery
- EBS in Children with De Novo Pathogenic Variants Disturbing Krt14
- Contact Dermatitis
- TACRINE
- Alopecia Areata in Twins With Autoimmune Thyroiditis: Personal Observations
- P‐51 Drug‐induced erythema multiforme or drug‐induced pemphigus foliaceus: a case report
- Ichthyosis with confetti: a rare diagnosis and treatment plan
- COVID-19 pandemic and teledermatology in low-income regions
- 14 Dermatological drugs, topical agents, and cosmetics